GLP-1 Analysis: Riding the Wave of Peptide Innovation - Takeaways - MDSpire

GLP-1 Analysis: Riding the Wave of Peptide Innovation

The remarkable commercial success of GLP-1 receptor agonists is fueling investment, accelerating science, and creating new analytical challenges. Here, we outline the hurdles these peptides present, explore methods for impurity profiling and structural characterization, and consider strategies to keep pace with this fast-moving field.

  • By

  • Amanda M. Guiraldelli

  • Piotr Alvarez

  • Koen Sandra

  • January 26, 2026

  • 17 min

Share

  • 1

    GLP-1 receptor agonists have gained popularity due to their effectiveness in treating type 2 diabetes and obesity, expanding their therapeutic applications.

  • 2

    Innovations in peptide therapeutics include multi-agonist therapies and advanced drug delivery systems, enhancing efficacy and patient adherence.

  • 3

    Oral formulations of GLP-1 RAs, like oral semaglutide, represent significant advancements in peptide drug delivery, improving convenience for patients.

  • 4

    Analytical challenges in peptide therapeutics necessitate fit-for-purpose methods to detect impurities and ensure product quality during development.

  • 5

    The commercial success of GLP-1 RAs has spurred investment in next-generation therapies, focusing on safety, convenience, and innovative delivery methods.

Original Source(s)

GLP-1 Analysis: Riding the Wave of Peptide Innovation

  • by Amanda M. Guiraldelli, Piotr Alvarez, Koen Sandra

  • January 26, 2026

Related Content

Effect of weight loss intervention on assisted reproductive outcomes in women with obesity and infertility: a retrospective cohort study

The immunometabolic mechanisms and therapeutic targets of metabolic dysfunction-associated steatohepatitis

After the Prescription: The Clinical Support Gap in Telehealth-Based GLP-1 Care